Farallon Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $287K | Hold |
|
|||||
|
2025
Q1 | $308K | Hold |
|
|||||
|
2024
Q4 | $353K | Hold |
|
|||||
|
2024
Q3 | $358K | Sell |
|
|||||
|
2024
Q2 | $45.6M | Buy |
|
|||||
|
2024
Q1 | $25.3M | Sell |
|
|||||
|
2023
Q4 | $105M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $42.7M | Sell |
|
|||||
|
2023
Q1 | $149M | Buy |
|
|||||
|
2022
Q4 | $182M | Buy |
|
|||||
|
2022
Q3 | $115M | Buy |
|
|||||
|
2022
Q2 | $92.5M | Buy |
|
|||||
|
2022
Q1 | $68.1M | Buy |
|
|||||
|
2021
Q4 | $69.3M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $42.4M | Sell |
|
|||||
|
2020
Q1 | $34.6M | Buy |
|